C

GP-Act III Acquisition Corp. GPAT

$10.97 $0.040.37% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

GP-Act III Acquisition Corp. (NASDAQ: GPAT) was a special purpose acquisition company (SPAC) formed to identify, evaluate, and complete a merger, capital stock exchange, asset acquisition, reorganization, or similar business combination with one or more businesses. The company operated within the financial services and capital markets sector, specifically the SPAC segment, and did not conduct traditional commercial operations or generate operating revenue prior to pursuing a business combination. Public filings described its focus as broad and industry-agnostic, although management indicated interest in sectors where its sponsors and executives possessed operational and investment experience.

The company was sponsored by GP-Act III Sponsor LLC, an affiliate associated with investment professionals connected to The Gores Group and Act III Holdings. GPAT completed its initial public offering in 2021 and raised capital through the sale of units consisting of shares and warrants, with proceeds held in a trust account pending a transaction. Like many SPACs formed during the 2020–2021 market cycle, the company’s strategic purpose centered on sourcing an acquisition target capable of transitioning into the public markets through a de-SPAC transaction. Public disclosures indicate that the company’s evolution remained tied primarily to identifying a suitable merger candidate rather than building standalone operating businesses.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Friday, August 14, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
212 430 4340
Address
300 Park Avenue
2nd Floor
New York, NY 10022
Country
Year Founded